Anupam Rasayan schedules Q4FY26 earnings call on May 25

1 min read     Updated on 21 May 2026, 12:36 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Anupam Rasayan India Limited announced an earnings call for May 25, 2026, at 05:30 PM IST to discuss Q4 and FY26 audited results. Senior management, including the MD and CEO, will lead the discussion. Pre-registration is required, with access numbers available for multiple regions.

powered bylight_fuzz_icon
40849588

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited has scheduled an earnings call to discuss the audited financial results for the quarter and financial year ended March 31, 2026. The meeting will be conducted under Regulation 30(6) of the SEBI Listing Regulations and is set to take place on May 25, 2026, at 05:30 PM IST.

Earnings Call Details

The company will review its standalone and consolidated performance for Q4 and FY26 during the session. Management will address the operational and financial outcomes of the specified period. Participants are required to pre-register for the event using the provided link to gain access.

Key Participants

The earnings call will feature senior leadership from the company, providing insights into the quarterly and annual performance. The roster of participants includes the Managing Director, Chief Executive Officer, and other financial heads.

Designation Name
Managing Director Mr. Anand Desai
Chief Executive Officer Mr. Gopal Agrawal
Chief Financial Officer Mr. Amit Khurana
Deputy Chief Financial Officer Mr. Vishal Thakkar

Access Information

Interested participants can join the conference call using various access numbers provided for different regions. The company has listed specific primary and toll-free numbers for attendees in India, the USA, the UK, Singapore, and Hong Kong.

Category Access Numbers
Primary Number +91 22 6280 1488, +91 22 7115 8869
Toll Free (USA) 1 866 746 2133
Toll Free (UK) 0 808 101 1573
Toll Free (Singapore) 800 101 2045
Toll Free (Hong Kong) 800 964 448

Strategic Growth Advisors Pvt. Ltd. is managing the RSVP for the event. Stakeholders can contact Mr. Shrikant Sangani or Ms. Shaily Patwa for further inquiries regarding the registration process.

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-0.06%+4.98%+16.54%+42.80%+78.11%

How has Anupam Rasayan's revenue from long-term contracts with multinational agrochemical and pharmaceutical companies evolved in FY26, and what is the pipeline for new contract signings in FY27?

Given the global shift toward specialty chemicals and China+1 sourcing strategies, how is Anupam Rasayan positioned to capture incremental market share in FY27 and beyond?

What capital expenditure plans has management outlined for FY27, and how will these investments impact the company's capacity utilization and margin profile going forward?

Anupam Rasayan board to consider FY26 results, dividend

1 min read     Updated on 20 May 2026, 11:57 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Anupam Rasayan India Limited's board is scheduled to meet on May 23, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026. Additionally, the board will evaluate a proposal to recommend a final dividend for FY 2025-26 and approve raising INR 160 crore through the issuance of secured non-convertible debentures on a private placement basis.

powered bylight_fuzz_icon
40846914

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited has scheduled a meeting of its Board of Directors on Saturday, May 23, 2026. The primary agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 31, 2026. These results will cover both standalone and consolidated financial statements.

In addition to the financial results, the board will consider recommending a final dividend on equity shares for the financial year 2025-26. The declaration of a dividend is subject to the approval of the shareholders.

The board will also deliberate on a proposal to raise funds. The company plans to issue 16,000 secured rated unlisted redeemable non-convertible debentures (NCDs) with a face value of INR 1,00,000 each. The total amount proposed to be raised through this private placement is INR 160,00,00,000 (₹160 crore).

Key Agenda Items

  • Consider and approve audited financial results (Standalone and Consolidated) for Q4 and FY26.
  • Consider and recommend final dividend for FY 2025-26.
  • Approve fund raising via issuance of NCDs amounting to ₹160 crore.

Fund Raising Details

Particulars Details
Instrument Type Secured Rated Unlisted Redeemable Non-Convertible Debentures
Number of NCDs 16,000
Face Value per NCD INR 1,00,000
Total Issue Size INR 160,00,00,000 (₹160 crore)
Basis Private Placement

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the company was closed from April 01, 2026. This closure period will end on May 25, 2026, which is 48 hours after the declaration of the financial results.

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-0.06%+4.98%+16.54%+42.80%+78.11%

How will Anupam Rasayan deploy the ₹160 crore raised through NCDs, and could this signal a major capacity expansion or acquisition in the specialty chemicals sector?

Given the NCD issuance at a private placement level, what does this suggest about the company's current debt-to-equity ratio and its long-term capital structure strategy?

How might Anupam Rasayan's FY26 financial performance compare to peers in the specialty chemicals industry amid ongoing global supply chain realignments and China+1 tailwinds?

More News on Anupam Rasayan

1 Year Returns:+42.80%